| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2008;39:2522.)
© 2008 American Heart Association, Inc.
Original Contributions |
From the Stroke Research Unit, Division of Neurology, Department of Medicine (G.S.), St. Michaels Hospital, University of Toronto, Ontario, Canada; the Institute of Clinical Evaluative Sciences (J.F.), Toronto, Ontario, Canada; the Department of Medicine (M.O.), McMaster University, Ontario, Canada; the Stroke Program, Department of Clinical Neurological Sciences (V.H.) London Health Sciences Center, University of Western Ontario, Canada; the Department of Health Policy (G.S., M.K.K.), Management and Evaluation, University of Toronto, Ontario, Canada; the Division of General Internal Medicine and Clinical Epidemiology (M.K.K.), Department of Medicine, University Health Network, Toronto, Ontario, Canada and University Health Network Womens Health Program Toronto, Ontario, Canada; and Stroke Unit, Departments of Clinical Neurosciences/Medicine/Community Health Sciences (M.D.H.), University of Calgary, Alberta, Canada.
Correspondence to Dr Gustavo Saposnik, 55 Queen St East, Suite 931, St Michaels Hospital, University of Toronto, Toronto, M5C 1R6, Canada. E-mail saposnikg{at}smh.toronto.on.ca
| Abstract |
|---|
|
|
|---|
Methods— Cohort study including patients with acute ischemic stroke between July 2003 and March 2005 in the Registry of the Canadian Stroke Network (RCSN). The RCSN is the largest clinical database of patients with acute stroke patients seen at selected acute care hospitals in Canada. As stroke unit admission does not automatically imply receipt of comprehensive care, we created the organized care index to represent different levels of access to organized care ranging from 0 to 3 as determined by the presence of occupational therapy/physiotherapy, stroke team assessment, and admission to a stroke unit. The primary end point was early stroke mortality. Secondary end points include 30-day and 1-year mortality.
Results— Overall, 3631 ischemic stroke patients were admitted to 11 hospitals. Seven day stroke mortality was 6.9% (249/3631), 30-day stroke mortality was 12.6% (457/3631), and 1-year stroke mortality was 23.6% (856/3631). Risk-adjusted 7-day mortality was 2.0%, 3.2%, 7.8%, and 22.5% for organized care index of 3, 2, 1, and 0. Higher level of care was associated with lower adjusted mortality (for organized care index 3, OR 0.03, 95% CI 0.02 to 0.07 for 7-day mortality; OR 0.09, 95% CI 0.05 to 0.17 for 30-day mortality; and OR 0.40, 95% CI 0.25 to 0.64 for 1-year mortality).
Conclusions— Higher level of access to care was associated with lower stroke mortality rates. Establishing a well-organized and multidisciplinary system of stroke care will help improve the quality of service delivered and reduce the burden of stroke.
Key Words: outcome research access to care organized care health policy stroke team
| Introduction |
|---|
|
|
|---|
Our aim was to determine whether escalating levels of organized inpatient care can improve stroke mortality. If confirmed, the identification of levels of organized care may constitute a proxy measure of quality of stroke care and help develop quality improvement strategies.
| Methods |
|---|
|
|
|---|
A stroke neurologist served as a project leader at each site and trained neurology research nurses performed patient recruitment and data entry based on chart review and patient and family interviews. Every 2 years the RCSN has performed a province-wide audit of stroke care in Ontario since fiscal year 2002/03. Chart validation studies have shown excellent agreement with the RCSN database, with kappa scores of >0.8 for key variables (age, sex, stroke type, thrombolysis use, comorbid conditions). Unpublished data revealed a high accuracy rate between the Discharge Abstract database (DAD), which contains data on all hospitalizations across Canada and RCSN for stroke admissions.
We used the Charlson-Deyo index to quantify patients comorbidities.13 This index is a summary score based on the presence or absence of 17 medical conditions. A score of zero indicates that no comorbidities are present, and higher scores indicate a greater burden of comorbidity. Based on their Charlson-Deyo index score, patients were categorized as having 0, 1, 2, or more than 3 comorbidities.14,15 Stroke severity was assessed by using the Canadian Neurological Scale (CNS).16,17 The CNS is a simple, reliable, and validated scale that gives a score (the lower the score the higher the severity) for estimating the acute neurological status. Neurological deterioration was determined by the local attending physician based on deterioration of the neurological deficit from admission or deterioration in the level of consciousness during hospitalization. Stroke unit was defined as a geographically located hospital unit with a dedicated stroke team and stroke resources (eg, care pathway, educational materials, and monitored beds). This unit does not need to have all these resources nor does it have to be exclusively for stroke patients, but it must be in one location in the hospital. Stroke team was defined as a multidisciplinary group of stroke specialists including physicians, nurses, occupational therapists, physiotherapists, and speech language pathologists. Assessment by any of these allied health professionals was recorded in the RCSN as a visit at any point during the hospitalization. Use of antithrombotic drugs was defined as the exposure to any antiplatelet or anticoagulant agents during the hospitalization. Pneumonia was included as a medical complication if it occurred within the first 30 days of the hospital stay and was confirmed radiologically. Length of stay was defined as the number of days in the acute care facility from admission to discharge to the previous place of residence, rehabilitation institution, or death.
Each hospital in the RCSN is assigned a unique, encrypted identifier. This identifier was used to determine the annual acute ischemic stroke volume for each hospital that contributed to the database. Data were entered electronically, and the aggregate anonymous database was managed at the Institute for Clinical Evaluative Sciences in Toronto, Ontario. Approval for the RCSN was obtained from the Research Ethics Board at each participating institution. The design of the study was also approved by the Ethics Review Boards at St Michaels Hospital, by the RCSN publications committee, and the Sunnybrook Hospital Research Ethics Board.
Assessment of Exposure: The Organized Care Index
As stroke unit admission does not automatically imply receiving comprehensive care and individual interventions (stroke team alone, stroke unit alone or occupational therapy [OT] and physiotherapy [PT] consultation and treatment alone) had a limited impact on stroke mortality, we created an index to represent different levels of access to organized care. This index was created based on the correlation among these variables and the individual impact on stroke mortality in the study cohort (n=3631). PT and OT were highly correlated (spearman correlation coefficient [95% CI]=0.72 [0.69 to 0.75]), but low correlations existed among OT/PT, stroke team assessment, or admission to the stroke unit (spearman correlation coefficients <0.31; see supplemental Table I, available online at http://stroke.ahajournals.org). Speech language pathology was not included in the score. Therefore, the organized care index (OCI) is a summary score based on the presence of occupational therapy or physiotherapy, stroke team assessment, and admission to a stroke unit. A score of zero indicates that stroke patients received none of these services, and higher scores indicate access to more services. The "organized care" index was classified as having received 0, 1, 2, or 3 services.
|
Outcome Measures
Stroke mortality was analyzed by using the 7-day, 30-day, and 1-year mortality health indicators. Stroke fatality was chosen as the main outcome because it is clinically relevant, objectively measured, and reliably coded. The primary outcome was early-stroke mortality measured by the 7-day mortality indicator. The use of 7-day mortality indicator has several advantages, including high case ascertainment and the limited impact of length of stay. The adjustment for stroke severity and other crucial factors that directly affect mortality constitute an advantage using this indicator when comparing stroke mortality between different regions, provinces, or countries, particularly when limited follow-up is available after discharge. Secondary outcomes include 30-day and 1-year mortality. Previous population-based studies and randomized clinical trials have used these indicators.18–25 Seven-day stroke mortality was defined as the proportion of ischemic stroke events that are fatal within 7 days from the onset. Thirty-day and 1-year stroke mortality were defined accordingly.
Statistical Analysis
Chi-square tests were used to compare categorical variables; ANOVA or Kruskal-Wallis tests were used to compare mean and median differences for continuous variables. Age was categorized as <60, 60 to 79, and >80 years old, and stroke severity was categorized a priori as mild (CNS >8) and moderate (CNS 5 to 7)/severe stroke (CNS
4) on the basis of previous studies.26,27 Logistic regression models were developed to determine the association of age, gender, stroke severity, clinical presentation, comorbid conditions, major medical complications (pneumonia, deep venous thrombosis, pulmonary embolism, Intracerebral hemorrhage), and the organized care index with mortality after stroke. Continuous variables were entered in the multivariable analysis as continuous. Age, stroke severity, level of consciousness were included a priori in the model as previously identified as independent predictor of stroke mortality.28,29 Other variables were considered for inclusion in the multivariable models if they were significant at the P<0.20 level in the univariate analysis. Statistical analysis was performed using a commercially available software package (SAS statistical software (1999), Version 9.1.3; SAS Institute Inc). All tests were 2-tailed, and probability values <0.05 were considered significant.
Role of the Funding Source
The sponsor of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The investigators had access to the data in the study and had final decision to submit for publication.
| Results |
|---|
|
|
|---|
|
|
Patients with lower level of care (organized care index=0) were younger, had lesser severe strokes (mean CNS score 8.5 versus 7.6), and higher proportion of decreased level of consciousness on admission (29% versus 11.5%) than patients who received greater levels of care (organized care index=3). No significant differences were observed in the prevalence of vascular risk factors, comorbidities, or prior history of TIA or stroke among 4 groups by organized stroke care index over 4 groups.
Access to Care and Stroke Mortality
Overall, stroke case-fatality was 6.9% (249/3631), 12.6% (457/3631), and 23.6% (856/3631) at 7 days, 30 days, and 1 year, respectively. Access to higher levels of organized care was associated with lower mortality (Table 2). Table 3 summarizes the unadjusted odds ratios for all mortality indicators. OT/PT assessment, evaluation by the stroke team, admission to the stroke unit, and all the categories of organized care index were associated with 7-day, 30-day, and 1-year stroke mortality. Risk-adjusted 7-day mortality rates were 2.0%, 3.2%, 7.8%, and 22.5% for organized care index 3, 2, 1, and 0 (Figure 1). In a stratified analysis by level of consciousness and stroke severity (CNS
4, 5 to 7 and
8), escalating levels of access to care improved stroke survival at 7 days, 30 days, and 1 year (Table 4).
|
|
|
|
In the multivariable analyses, organized care remained as an independent predictor of 7-day mortality after adjusting for age, gender, stroke severity, neurological worsening, comorbid conditions, antiplatelet use, and other covariates. For the secondary end points, higher level of care was also associated with lower stroke mortality (Table 5). The results also remained robust after excluding postadmission events such as neurological deterioration or patients treated palliatively (DNR order) or patients who were unconscious at admission in the multivariable analysis. Figure 2 shows a stroke mortality by organized care index in patients with moderate/severe stroke (CNS score lower than 7).
|
|
| Discussion |
|---|
|
|
|---|
Delivery of stroke care has been the subject of debate. Although stroke units have been associated with higher survival and reduce disability after stroke, it is unclear what components of care are associated with better outcomes.2,30 Interestingly, the broad variability of care provided and terms used to defined "stroke unit care" does not automatically warrant that an admission to the stroke unit will be synonymous with comprehensive care (assessment by stroke neurologist, occupational therapy or physiotherapy).31–33 In addition, the impact of any of these individual interventions has a limited effect on stroke outcome.2,34,35 For example, in a recent systematic review care provided by a mobile stroke team had no major impact on death, dependency, or need for institutional care.3 A meta-analysis assessed the impact of OT, the pooled high-quality studies show small but significant effect on activities of daily living and social participation.34 Although these studies may endorse the importance of OT, PT, and stroke team, our study is unique in providing evidence that organized and multidisciplinary care decreases stroke mortality.
In the real world, different interventions are available for the treatment of acute stroke (intravenous, intraarterial thrombolysis) but only a few patients are eligible.36 The vast majority of patients (thus far) will require highly specialized care to facilitate early rehabilitation, preventing complications for reducing disability after stroke.
There are some strengths as well as limitations that deserve comment. First, our study includes only patients admitted to stroke centers, which may not reflect care received and mortality rates in other facilities. However, the RCSN attempts to include all consecutive patients with acute stroke at all of the participating hospitals to reduce any selection bias. It contains detailed patient-level information that allows us comparing mortality indicators including demographic, clinical, and interventional data, not otherwise available in larger administrative databases. Second, as dependency was not studied, we cannot rule out that decreased fatality rates would be followed by increased dependency rates. Third, it is possible that fewer patients who die early receive some interventions (occupational therapy, physiotherapy, antithrombotic therapy, etc) because of administrative or practical reasons resulting in an overestimation of the magnitude of the effect. Fourth, unmeasured variables not included in the analysis (for example, time of PT/OT assessment, number of OT/PT consults) may have influenced the results.
Despite these limitations, by introducing the organized care index, our study provides strong evidence that higher access to different levels of care is associated with better stroke outcomes independently of the level of consciousness and stroke severity. These results were consistent through all mortality indicators. This study is unique in providing evidence in favor of the argument that stroke patients are best served by a comprehensive and specialized inpatient care and not by individual interventions. This very issue is under intense debate in the stroke world as hospitals organize services to meet the needs of stroke victims. It is sometimes difficult to understand that a "stroke unit" or "physiotherapy" is a treatment, in much the same way as a pharmacological intervention or a medical procedure (e.g.: coronary artery by pass graft, thrombolytic therapy or appendectomy).
In terms of the impact of optimal care on stroke outcome, we found that stroke mortality was reduced approximately 10 times when comparing adjusted mortality rate for organized care index 2 or 3 (highest levels of care) versus organized care index 0 (lowest level of care; Figure 1). The number needed to treat (NNT) to prevent 1 death if all patients would received optimal care (organized care index=3 versus organized care index 0) is low (NNT=5 for 7 and 30-day mortality and NNT 6 for 1-year mortality). The NNTs are similar when comparing organized care index=2 versus organized care index=0 (NNT=5). This is similar to the impact of highly effective interventions such as intravenous thrombolysis for acute stroke or carotid endarterectomy for patients with symptomatic and severe carotid stenosis.36,37 More interestingly, the absolute number of patients that could benefit from high access to organized care is more dramatic, considering the attributable risk proportion of death and the population at risk. Our study serves to provide "real-world" evidence of the effectiveness of organized stroke care.
There are some contradictions when comparing current available guidelines and recommendations. Despite scientific evidence available for more than a decade on the effectiveness of the stroke units, organized care (OT, PT, SLP, Stroke teams) is not fully implemented in practice in different hospitals receiving high stroke volumes. Furthermore, occupational therapy, physiotherapy, and speech language pathology are not mentioned as part of the "stroke team" or as a key element for primary stroke centers in the AHA/ASA Guidelines for the early management of acute ischemic stroke in adults.1
We hope that our study provides evidence that not only stroke team and the stroke units are crucial but, also, the expertise provided by physiotherapist and occupational therapists as part of the multidisciplinary team may help reduce stroke mortality and overall improve patients outcomes.
Practical Implications and Future directions
Information on the processes of care in the first hours or days after stroke is critical, but limited. In agreement with previous studies, there is considerable scope for improving quality of stroke care by understanding the processes of care in the acute phase of stroke, irrespective of the age, gender, facility type, and expertise in stroke management. Interestingly, the "organized care index" may be a proxy measure of the resources available at each facility and an indicator of quality of hospital care. Moreover, the beneficial effect of escalating levels of care is probably not specific for stroke, but also to other neurological conditions. Although some aspects of acute care such as blood pressure control, use of lipid lowering therapy, or glucose management are more easily the subject of randomized controlled trials, it is more difficult to justify randomization of simple first aid measures such as physiotherapy or stroke team assessment.
Although no direct inferences about quality of care should be drawn from the data presented here, our study serves as a useful starting point to highlight issues or raise questions about outcomes and processes of stroke care.
In summary, escalating levels of access to care were associated with lower stroke mortality rates. Establishing well-organized systems aiming to improve the access to more specialized care for stroke patients is a major challenge for all hospitals, regions, and countries. Escalating levels of care may imply higher cost and subsequently redefinition of priorities in resource allocation. The understanding of processes of care and the mutual cooperation among professionals and health care providers may help develop more effective strategies to improve the quality of stroke care.
| Acknowledgments |
|---|
Sources of Funding
This research was supported in part by grants from Heart Stroke Foundation of Canada (HSFC), Canadian Institutes for Health Research (CIHR), Department of Research at St Michaels Hospital and Connaught Foundation (University of Toronto) given to Dr Gustavo Saposnik. Dr Gustavo Saposnik is supported by the Clinician-Scientist Award from Heart Stroke Foundation Ontario. Dr Martin O'Donnell is supported by a grant from the CIHR. Dr Moira Kapral is supported by a New Investigator Award from the CIHR and also received support from the Canadian Stroke Network and the University Health Network Womens Health Program. Dr Michael Hill is supported by the Heart &Stroke Foundation of Alberta/NWT/NU and the Alberta Heritage Foundation for Medical Research. These grants were obtained based on competitive applications after publication of grant advertisements. The investigators acted as the sponsors of the study. None of the supporting agencies had input on the design, access to the data, analyses, interpretation, or publication of the study.
Disclosures
None.
Received October 15, 2007; revision received January 14, 2008; accepted January 25, 2008.
| References |
|---|
|
|
|---|
2. Kalra L, Evans A, Perez I, Knapp M, Swift C, Donaldson N. A randomised controlled comparison of alternative strategies in stroke care. Health Technol Assess. 2005; 9: 1–94.[Medline] [Order article via Infotrieve]
3. Langhorne P, Dey P, Woodman M, Kalra L, Wood-Dauphinee S, Patel N, Hamrin E. Is stroke unit care portable? A systematic review of the clinical trials. Age Ageing. 2005; 34: 324–330.
4. Govan L, Langhorne P, Weir CJ. Does the prevention of complications explain the survival benefit of organized inpatient (stroke unit) care?: Further analysis of a systematic review. Stroke. 2007; 38: 2536–2540.
5. Alvarez Sabin J, Alonso de Lecinana M, Gallego J, Gil-Peralta A, Casado I, Castillo J, Diez Tejedor E, Gil A, Jimenez C, Lago A, Martinez-Vila E, Ortega A, Rebollo M, Rubio F. [plan for stroke healthcare delivery]. Neurologia. 2006; 21: 717–726.[Medline] [Order article via Infotrieve]
6. Kapral MK, Laupacis A, Phillips SJ, Silver FL, Hill MD, Fang J, Richards J, Tu JV. Stroke care delivery in institutions participating in the registry of the canadian stroke network. Stroke. 2004; 35: 1756–1762.
7. Low JT, Roderick P, Payne S. An exploration looking at the impact of domiciliary and day hospital delivery of stroke rehabilitation on informal carers. Clin Rehabil. 2004; 18: 776–784.
8. Stradling D, Yu W, Langdorf ML, Tsai F, Kostanian V, Hasso AN, Welbourne SJ, Schooley Y, Fisher MJ, Cramer SC. Stroke care delivery before vs after jcaho stroke center certification. Neurology. 2007; 68: 469–470.
9. Dey P, Woodman M, Gibbs A, Steele R, Stocks SJ, Wagstaff S, Khanna V, Chaudhuri MD. Early assessment by a mobile stroke team: A randomised controlled trial. Age Ageing. 2005; 34: 331–338.
10. Alberts MJ, Latchaw RE, Selman WR, Shephard T, Hadley MN, Brass LM, Koroshetz W, Marler JR, Booss J, Zorowitz RD, Croft JB, Magnis E, Mulligan D, Jagoda A, O'Connor R, Cawley CM, Connors JJ, Rose-DeRenzy JA, Emr M, Warren M, Walker MD. Recommendations for comprehensive stroke centers: A consensus statement from the brain attack coalition. Stroke. 2005; 36: 1597–1616.
11. Tu JV, Willison DJ, Silver FL, Fang J, Richards JA, Laupacis A, Kapral MK. Impracticability of informed consent in the registry of the canadian stroke network. N Engl J Med. 2004; 350: 1414–1421.
12. Moira K Kapral, Frank L. Silver, Janice A. Richards, Patrice Lindsay, Jiming Fang, Steven Shi, Michael D. Hill, Stephen J. Phillips, Annette Robertson, Jack V. Tu. Registry of the Canadian Stroke Network progress report 2001–2005. 2005.
13. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with icd-9-cm administrative databases. J Clin Epidemiol. 1992; 45: 613–619.[CrossRef][Medline] [Order article via Infotrieve]
14. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 1987; 40: 373–383.[CrossRef][Medline] [Order article via Infotrieve]
15. Goldstein LB, Samsa GP, Matchar DB, Horner RD. Charlson index comorbidity adjustment for ischemic stroke outcome studies. Stroke. 2004; 35: 1941–1945.
16. Cote R, Battista RN, Wolfson C, Boucher J, Adam J, Hachinski V. The canadian neurological scale: Validation and reliability assessment. Neurology. 1989; 39: 638–643.
17. Bushnell CD, Johnston DC, Goldstein LB. Retrospective assessment of initial stroke severity: Comparison of the NIH stroke scale and the Canadian neurological scale. Stroke. 2001; 32: 656–660.
18. Steiner T, Bluhmki E, Kaste M, Toni D, Trouillas P, von Kummer R, Hacke W. The ecass 3-hour cohort. Secondary analysis of ecass data by time stratification. ECASS study group. European cooperative acute stroke study. Cerebrovasc Dis. 1998; 8: 198–203.[CrossRef][Medline] [Order article via Infotrieve]
19. Lavados PM, Sacks C, Prina L, Escobar A, Tossi C, Araya F, Feuerhake W, Galvez M, Salinas R, Alvarez G. Incidence, 30-day case-fatality rate, and prognosis of stroke in Iquique, Chile: A 2-year community-based prospective study (PISCIS project). Lancet. 2005; 365: 2206–2215.[CrossRef][Medline] [Order article via Infotrieve]
20. Smith MA, Liou JI, Frytak JR, Finch MD. 30-day survival and rehospitalization for stroke patients according to physician specialty. Cerebrovasc Dis. 2006; 22: 21–26.[Medline] [Order article via Infotrieve]
21. Mihalka L, Smolanka V, Bulecza B, Mulesa S, Bereczki D. A population study of stroke in west Ukraine: Incidence, stroke services, and 30-day case fatality. Stroke. 2001; 32: 2227–2231.
22. Szczudiik A, Slowik A, Turaj W, Zwolinska G, Wyrwicz-Petkow U, Kasprzyk K, Bosak M. Early predictors of 30-day mortality in supratentorial ischemic stroke patients-first episode. Med Sci Monit. 2000; 6: 75–80.[Medline] [Order article via Infotrieve]
23. Ellekjaer H, Holmen J, Indredavik B, Terent A. Epidemiology of stroke in innherred, norway, 1994 to 1996. Incidence and 30-day case-fatality rate. Stroke. 1997; 28: 2180–2184.
24. Feigin VL, Wiebers DO, Whisnant JP, O'Fallon WM. Stroke incidence and 30-day case-fatality rates in Novosibirsk, Russia, 1982 through 1992. Stroke. 1995; 26: 924–929.
25. Azzimondi G, Bassein L, Fiorani L, Nonino F, Montaguti U, Celin D, Re G, D'Alessandro R. Variables associated with hospital arrival time after stroke: Effect of delay on the clinical efficiency of early treatment. Stroke. 1997; 28: 537–542.
26. Muir KW, Weir CJ, Murray GD, Povey C, Lees KR. Comparison of neurological scales and scoring systems for acute stroke prognosis. Stroke. 1996; 27: 1817–1820.
27. D'Olhaberriague L, Litvan I, Mitsias P, Mansbach HH. A reappraisal of reliability and validity studies in stroke. Stroke. 1996; 27: 2331–2336.
28. Baptista MV, van Melle G, Bogousslavsky J. Prediction of in-hospital mortality after first-ever stroke: The Lausanne stroke registry. J Neurol Sci. 1999; 166: 107–114.[CrossRef][Medline] [Order article via Infotrieve]
29. Heuschmann PU, Kolominsky-Rabas PL, Misselwitz B, Hermanek P, Leffmann C, Janzen RW, Rother J, Buecker-Nott HJ, Berger K. Predictors of in-hospital mortality and attributable risks of death after ischemic stroke: The German stroke registers study group. Arch Intern Med. 2004; 164: 1761–1768.
30. Jorgensen HS, Nakayama H, Raaschou HO, Larsen K, Hubbe P, Olsen TS. The effect of a stroke unit: Reductions in mortality, discharge rate to nursing home, length of hospital stay, and cost. A community-based study. Stroke. 1995; 26: 1178–1182.
31. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev. 2002: CD000197.
32. How do stroke units improve patient outcomes? A collaborative systematic review of the randomized trials. Stroke unit trialists collaboration. Stroke. 1997; 28: 2139–2144.
33. Langhorne P The main components of stroke unit care: What is the question? Cerebrovasc Dis. 2007; 23: 464; author reply 465.[CrossRef][Medline] [Order article via Infotrieve]
34. Steultjens EM, Dekker J, Bouter LM, van de Nes JC, Cup EH, van den Ende CH. Occupational therapy for stroke patients: A systematic review. Stroke. 2003; 34: 676–687.
35. Langhorne P. Review: Comprehensive occupational therapy interventions improve outcomes after stroke. ACP J Club. 2004; 140: 7.[Medline] [Order article via Infotrieve]
36. Schellinger PD, Kaste M, Hacke W. An update on thrombolytic therapy for acute stroke. Curr Opin Neurol. 2004; 17: 69–77.[CrossRef][Medline] [Order article via Infotrieve]
37. Rothwell PM Effective stroke prevention in patients with symptomatic carotid stenosis. Cerebrovasc Dis. 2004; 17: 89–104.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
G. Saposnik, M. K. Kapral, S. B. Coutts, J. Fang, A. M. Demchuk, M. D. Hill, and on behalf of the Investigators of the Registry of Do All Age Groups Benefit From Organized Inpatient Stroke Care? Stroke, October 1, 2009; 40(10): 3321 - 3327. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Saposnik, S. E. Black, A. Hakim, J. Fang, J. V. Tu, M. K. Kapral, and on behalf of the Investigators of the Registry of Age Disparities in Stroke Quality of Care and Delivery of Health Services Stroke, October 1, 2009; 40(10): 3328 - 3335. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Rudd and L. S. Williams Advances in Health Policy and Outcomes Stroke, May 1, 2009; 40(5): e301 - e304. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |